Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human P2Y2 ELISA Kit (AC3484)
Cat.#: ASET-2073
Specifications
Description Human P2Y2 ELISA Kit allows for the in vitro quantitative determination of human P2Y2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 14.063 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 23.438-1500 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2356 Rat DDAH2 ELISA Kit (AC3767) Quantitative inquiry ASET-1486 Mouse beta MSH ELISA Kit (AC2897) Quantitative inquiry ASET-1222 Human PDE7B ELISA Kit (AC2633) Quantitative inquiry ASET-1199 Rat Neuropeptide Y ELISA Kit (AC2610) Quantitative inquiry ASET-1359 Mouse Creatine Kinase B Type ELISA Kit (AC2770) Quantitative inquiry ASET-1321 Human Dopamine Transporter ELISA Kit (AC2732) Quantitative inquiry ASET-2543 Human Neuropilin 1 ELISA Kit (AC3954) Quantitative inquiry ASET-2117 Human Sema6A ELISA Kit (AC3528) Quantitative inquiry ASET-2072 Mouse GDF11 ELISA Kit (AC3483) Quantitative inquiry ASET-2202 Human Estrogen Receptor beta ELISA Kit (AC3613) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket